Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 553 entries
Sorted by: Best Match Show Resources per page
Ordered mesoporous materials as solid supports for rhodium-diphosphine catalysts with remarkable hydroformylation activity.

Chemical communications (Cambridge, England)

Marras F, Wang J, Coppens MO, Reek JN.
PMID: 20697633
Chem Commun (Camb). 2010 Sep 21;46(35):6587-9. doi: 10.1039/c0cc00924e. Epub 2010 Aug 09.

A rhodium-diphosphine complex based on Xantphos-type ligands was anchored on mesoporous silica SBA-15, and the material showed remarkably high catalytic activity in the hydroformylation of 1-octene, even exceeding its homogeneous analogue under certain conditions.

Cite
Marras F, Wang J, Coppens MO, et al. Ordered mesoporous materials as solid supports for rhodium-diphosphine catalysts with remarkable hydroformylation activity. Chem Commun (Camb). 2010;46(35):6587-9doi: 10.1039/c0cc00924e.
Marras, F., Wang, J., Coppens, M. O., & Reek, J. N. (2010). Ordered mesoporous materials as solid supports for rhodium-diphosphine catalysts with remarkable hydroformylation activity. Chemical communications (Cambridge, England), 46(35), 6587-9. https://doi.org/10.1039/c0cc00924e
Marras, Fabrizio, et al. "Ordered mesoporous materials as solid supports for rhodium-diphosphine catalysts with remarkable hydroformylation activity." Chemical communications (Cambridge, England) vol. 46,35 (2010): 6587-9. doi: https://doi.org/10.1039/c0cc00924e
Marras F, Wang J, Coppens MO, Reek JN. Ordered mesoporous materials as solid supports for rhodium-diphosphine catalysts with remarkable hydroformylation activity. Chem Commun (Camb). 2010 Sep 21;46(35):6587-9. doi: 10.1039/c0cc00924e. Epub 2010 Aug 09. PMID: 20697633.
Copy Download .nbib Format: NLM
Compounding Pharmacists Unhappy With New FDA Guidance Documents : Rules Severely Limit Distribution.

P & T : a peer-reviewed journal for formulary management

Barlas S.
PMID: 27504061
P T. 2016 Aug;41(8):466-91.

Recent FDA compounding guidances raise hackles.

Cite
Barlas S. Compounding Pharmacists Unhappy With New FDA Guidance Documents : Rules Severely Limit Distribution. P T. 2016;41(8):466-91
Barlas, S. (2016). Compounding Pharmacists Unhappy With New FDA Guidance Documents : Rules Severely Limit Distribution. P & T : a peer-reviewed journal for formulary management, 41(8), 466-91.
Barlas, Stephen. "Compounding Pharmacists Unhappy With New FDA Guidance Documents : Rules Severely Limit Distribution." P & T : a peer-reviewed journal for formulary management vol. 41,8 (2016): 466-91.
Barlas S. Compounding Pharmacists Unhappy With New FDA Guidance Documents : Rules Severely Limit Distribution. P T. 2016 Aug;41(8):466-91. PMID: 27504061; PMCID: PMC4959613.
Copy Download .nbib Format: NLM
Congress and Federal Agencies Address Opioid Abuse Epidemic, But Will New Initiatives Be Successful?.

P & T : a peer-reviewed journal for formulary management

Barlas S.
PMID: 27504065
P T. 2016 Aug;41(8):488-91.

In response to the alarming rate of opioid overdose deaths in the U.S., the President, Congress, and federal agencies are making efforts to reduce the number of fatalities.

Cite
Barlas S. Congress and Federal Agencies Address Opioid Abuse Epidemic, But Will New Initiatives Be Successful?. P T. 2016;41(8):488-91
Barlas, S. (2016). Congress and Federal Agencies Address Opioid Abuse Epidemic, But Will New Initiatives Be Successful?. P & T : a peer-reviewed journal for formulary management, 41(8), 488-91.
Barlas, Stephen. "Congress and Federal Agencies Address Opioid Abuse Epidemic, But Will New Initiatives Be Successful?." P & T : a peer-reviewed journal for formulary management vol. 41,8 (2016): 488-91.
Barlas S. Congress and Federal Agencies Address Opioid Abuse Epidemic, But Will New Initiatives Be Successful?. P T. 2016 Aug;41(8):488-91. PMID: 27504065; PMCID: PMC4959617.
Copy Download .nbib Format: NLM
GAO Report Questions Rebates to Hospitals: An Accurate Accounting of Those GPO Rebates Is at Issue.

P & T : a peer-reviewed journal for formulary management

Barlas S.
PMID: 25673956
P T. 2015 Feb;40(2):83-114.

GAO eyes group purchasing organization hospital rebates.

Cite
Barlas S. GAO Report Questions Rebates to Hospitals: An Accurate Accounting of Those GPO Rebates Is at Issue. P T. 2015;40(2):83-114
Barlas, S. (2015). GAO Report Questions Rebates to Hospitals: An Accurate Accounting of Those GPO Rebates Is at Issue. P & T : a peer-reviewed journal for formulary management, 40(2), 83-114.
Barlas, Stephen. "GAO Report Questions Rebates to Hospitals: An Accurate Accounting of Those GPO Rebates Is at Issue." P & T : a peer-reviewed journal for formulary management vol. 40,2 (2015): 83-114.
Barlas S. GAO Report Questions Rebates to Hospitals: An Accurate Accounting of Those GPO Rebates Is at Issue. P T. 2015 Feb;40(2):83-114. PMID: 25673956; PMCID: PMC4315108.
Copy Download .nbib Format: NLM
FDA Considers More Rigorous Enforcement For Homeopathic Products Over Safety Risks: New Labeling Is Possible; Pre-Market Testing Seems Unlikely.

P & T : a peer-reviewed journal for formulary management

Barlas S.
PMID: 26185400
P T. 2015 Jul;40(7):414-68.

FDA may step up enforcement for homeopathic products.

Cite
Barlas S. FDA Considers More Rigorous Enforcement For Homeopathic Products Over Safety Risks: New Labeling Is Possible; Pre-Market Testing Seems Unlikely. P T. 2015;40(7):414-68
Barlas, S. (2015). FDA Considers More Rigorous Enforcement For Homeopathic Products Over Safety Risks: New Labeling Is Possible; Pre-Market Testing Seems Unlikely. P & T : a peer-reviewed journal for formulary management, 40(7), 414-68.
Barlas, Stephen. "FDA Considers More Rigorous Enforcement For Homeopathic Products Over Safety Risks: New Labeling Is Possible; Pre-Market Testing Seems Unlikely." P & T : a peer-reviewed journal for formulary management vol. 40,7 (2015): 414-68.
Barlas S. FDA Considers More Rigorous Enforcement For Homeopathic Products Over Safety Risks: New Labeling Is Possible; Pre-Market Testing Seems Unlikely. P T. 2015 Jul;40(7):414-68. PMID: 26185400; PMCID: PMC4495866.
Copy Download .nbib Format: NLM
Elastomeric Nanocomposite Foams for the Removal of Heavy Metal Ions from Water.

ACS applied materials & interfaces

Chavan AA, Li H, Scarpellini A, Marras S, Manna L, Athanassiou A, Fragouli D.
PMID: 26133912
ACS Appl Mater Interfaces. 2015 Jul 15;7(27):14778-84. doi: 10.1021/acsami.5b03003. Epub 2015 Jul 02.

We report the fabrication and utilization of elastomeric polymer nanocomposite foams for the efficient removal of Pb2+ and Hg2+ heavy metal ions from polluted water. The polydimethylsiloxane (PDMS) foams are properly modified in order to become hydrophilic and allow...

Cite
Chavan AA, Li H, Scarpellini A, et al. Elastomeric Nanocomposite Foams for the Removal of Heavy Metal Ions from Water. ACS Appl Mater Interfaces. 2015;7(27):14778-84doi: 10.1021/acsami.5b03003.
Chavan, A. A., Li, H., Scarpellini, A., Marras, S., Manna, L., Athanassiou, A., & Fragouli, D. (2015). Elastomeric Nanocomposite Foams for the Removal of Heavy Metal Ions from Water. ACS applied materials & interfaces, 7(27), 14778-84. https://doi.org/10.1021/acsami.5b03003
Chavan, Asmita A, et al. "Elastomeric Nanocomposite Foams for the Removal of Heavy Metal Ions from Water." ACS applied materials & interfaces vol. 7,27 (2015): 14778-84. doi: https://doi.org/10.1021/acsami.5b03003
Chavan AA, Li H, Scarpellini A, Marras S, Manna L, Athanassiou A, Fragouli D. Elastomeric Nanocomposite Foams for the Removal of Heavy Metal Ions from Water. ACS Appl Mater Interfaces. 2015 Jul 15;7(27):14778-84. doi: 10.1021/acsami.5b03003. Epub 2015 Jul 02. PMID: 26133912.
Copy Download .nbib Format: NLM
Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas.

Genome medicine

Sha C, Barrans S, Care MA, Cunningham D, Tooze RM, Jack A, Westhead DR.
PMID: 26207141
Genome Med. 2015 Jul 01;7(1):64. doi: 10.1186/s13073-015-0187-6. eCollection 2015.

BACKGROUND: Classifiers based on molecular criteria such as gene expression signatures have been developed to distinguish Burkitt lymphoma and diffuse large B cell lymphoma, which help to explore the intermediate cases where traditional diagnosis is difficult. Transfer of these...

Cite
Sha C, Barrans S, Care MA, et al. Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas. Genome Med. 2015;7(1):64doi: 10.1186/s13073-015-0187-6.
Sha, C., Barrans, S., Care, M. A., Cunningham, D., Tooze, R. M., Jack, A., & Westhead, D. R. (2015). Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas. Genome medicine, 7(1), 64. https://doi.org/10.1186/s13073-015-0187-6
Sha, Chulin, et al. "Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas." Genome medicine vol. 7,1 (2015): 64. doi: https://doi.org/10.1186/s13073-015-0187-6
Sha C, Barrans S, Care MA, Cunningham D, Tooze RM, Jack A, Westhead DR. Transferring genomics to the clinic: distinguishing Burkitt and diffuse large B cell lymphomas. Genome Med. 2015 Jul 01;7(1):64. doi: 10.1186/s13073-015-0187-6. eCollection 2015. PMID: 26207141; PMCID: PMC4512160.
Copy Download .nbib Format: NLM
Dissecting metabolic syndrome components: data from an epidemiologic survey in a genetic isolate.

SpringerPlus

Biino G, Concas MP, Cena H, Parracciani D, Vaccargiu S, Cosso M, Marras F, D'Esposito V, Beguinot F, Pirastu M.
PMID: 26180744
Springerplus. 2015 Jul 07;4:324. doi: 10.1186/s40064-015-1049-9. eCollection 2015.

The metabolic syndrome (MetS) is a large-scale and expanding public-health and clinical threat worldwide. We investigated the determinants of MetS, assessed its prevalence and components and, estimated their genetic contribution, taking advantage of the special characteristics of Sardinian isolated...

Cite
Biino G, Concas MP, Cena H, et al. Dissecting metabolic syndrome components: data from an epidemiologic survey in a genetic isolate. Springerplus. 2015;4:324doi: 10.1186/s40064-015-1049-9.
Biino, G., Concas, M. P., Cena, H., Parracciani, D., Vaccargiu, S., Cosso, M., Marras, F., D'Esposito, V., Beguinot, F., & Pirastu, M. (2015). Dissecting metabolic syndrome components: data from an epidemiologic survey in a genetic isolate. SpringerPlus, 4324. https://doi.org/10.1186/s40064-015-1049-9
Biino, Ginevra, et al. "Dissecting metabolic syndrome components: data from an epidemiologic survey in a genetic isolate." SpringerPlus vol. 4 (2015): 324. doi: https://doi.org/10.1186/s40064-015-1049-9
Biino G, Concas MP, Cena H, Parracciani D, Vaccargiu S, Cosso M, Marras F, D'Esposito V, Beguinot F, Pirastu M. Dissecting metabolic syndrome components: data from an epidemiologic survey in a genetic isolate. Springerplus. 2015 Jul 07;4:324. doi: 10.1186/s40064-015-1049-9. eCollection 2015. PMID: 26180744; PMCID: PMC4493262.
Copy Download .nbib Format: NLM
Lorenzo Lotto's painting materials: an integrated diagnostic approach.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy

Amadori ML, Poldi G, Barcelli S, Baraldi P, Berzioli M, Casoli A, Marras S, Pojana G, Villa GC.
PMID: 27089184
Spectrochim Acta A Mol Biomol Spectrosc. 2016 Jul 05;164:110-22. doi: 10.1016/j.saa.2016.02.043. Epub 2016 Mar 31.

This paper presents the results of a comprehensive diagnostic investigation carried out on five paintings (three wood panels and two paintings on canvas) by Lorenzo Lotto, one of the most significant artists of the Italian Renaissance in the first...

Cite
Amadori ML, Poldi G, Barcelli S, et al. Lorenzo Lotto's painting materials: an integrated diagnostic approach. Spectrochim Acta A Mol Biomol Spectrosc. 2016;164:110-22doi: 10.1016/j.saa.2016.02.043.
Amadori, M. L., Poldi, G., Barcelli, S., Baraldi, P., Berzioli, M., Casoli, A., Marras, S., Pojana, G., & Villa, G. C. (2016). Lorenzo Lotto's painting materials: an integrated diagnostic approach. Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 164110-22. https://doi.org/10.1016/j.saa.2016.02.043
Amadori, Maria Letizia, et al. "Lorenzo Lotto's painting materials: an integrated diagnostic approach." Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy vol. 164 (2016): 110-22. doi: https://doi.org/10.1016/j.saa.2016.02.043
Amadori ML, Poldi G, Barcelli S, Baraldi P, Berzioli M, Casoli A, Marras S, Pojana G, Villa GC. Lorenzo Lotto's painting materials: an integrated diagnostic approach. Spectrochim Acta A Mol Biomol Spectrosc. 2016 Jul 05;164:110-22. doi: 10.1016/j.saa.2016.02.043. Epub 2016 Mar 31. PMID: 27089184.
Copy Download .nbib Format: NLM
Proposed Changes in Medicare Hospital Payments Would Affect Pharmacy and Beyond: Drug Companies Push to Rein in 340B Discount Drugs.

P & T : a peer-reviewed journal for formulary management

Barlas S.
PMID: 24273395
P T. 2013 Sep;38(9):497.

Drug companies push to rein in 340B discount drugs.

Cite
Barlas S. Proposed Changes in Medicare Hospital Payments Would Affect Pharmacy and Beyond: Drug Companies Push to Rein in 340B Discount Drugs. P T. 2013;38(9):497
Barlas, S. (2013). Proposed Changes in Medicare Hospital Payments Would Affect Pharmacy and Beyond: Drug Companies Push to Rein in 340B Discount Drugs. P & T : a peer-reviewed journal for formulary management, 38(9), 497.
Barlas, Stephen. "Proposed Changes in Medicare Hospital Payments Would Affect Pharmacy and Beyond: Drug Companies Push to Rein in 340B Discount Drugs." P & T : a peer-reviewed journal for formulary management vol. 38,9 (2013): 497.
Barlas S. Proposed Changes in Medicare Hospital Payments Would Affect Pharmacy and Beyond: Drug Companies Push to Rein in 340B Discount Drugs. P T. 2013 Sep;38(9):497. PMID: 24273395; PMCID: PMC3828935.
Copy Download .nbib Format: NLM
Prescription drug abuse hits hospitals hard: tighter federal steps aim to deflate crisis.

P & T : a peer-reviewed journal for formulary management

Barlas S.
PMID: 24273399
P T. 2013 Sep;38(9):531-4.

Hospitals and their pharmacy departments are now at the epicenter of the prescription drug-abuse tsunami. The Obama administration is using regulatory agencies in an to attempt to crack down on physician-run "pill mills" and the pharmacies that support them.

Cite
Barlas S. Prescription drug abuse hits hospitals hard: tighter federal steps aim to deflate crisis. P T. 2013;38(9):531-4
Barlas, S. (2013). Prescription drug abuse hits hospitals hard: tighter federal steps aim to deflate crisis. P & T : a peer-reviewed journal for formulary management, 38(9), 531-4.
Barlas, Stephen. "Prescription drug abuse hits hospitals hard: tighter federal steps aim to deflate crisis." P & T : a peer-reviewed journal for formulary management vol. 38,9 (2013): 531-4.
Barlas S. Prescription drug abuse hits hospitals hard: tighter federal steps aim to deflate crisis. P T. 2013 Sep;38(9):531-4. PMID: 24273399; PMCID: PMC3828933.
Copy Download .nbib Format: NLM
FDA starts new light-touch inspections for some imports.

P & T : a peer-reviewed journal for formulary management

Barlas S.
PMID: 25050052
P T. 2014 Jun;39(6):384-5.

FDA starts light-touch inspections for some imports.

Cite
Barlas S. FDA starts new light-touch inspections for some imports. P T. 2014;39(6):384-5
Barlas, S. (2014). FDA starts new light-touch inspections for some imports. P & T : a peer-reviewed journal for formulary management, 39(6), 384-5.
Barlas, Stephen. "FDA starts new light-touch inspections for some imports." P & T : a peer-reviewed journal for formulary management vol. 39,6 (2014): 384-5.
Barlas S. FDA starts new light-touch inspections for some imports. P T. 2014 Jun;39(6):384-5. PMID: 25050052; PMCID: PMC4103712.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 553 entries